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OBJECTIVE — Tocomparetheprevalenceinmetabolicsyndrome(MetSyn)between1988–
1994 and 1999–2006 among U.S. adults of different races or ethnicities.
RESEARCH DESIGN AND METHODS — Analysis of data on 6,423 adult men and
nonpregnant women aged 20 years from Third National Health and Nutrition Examination
Survey (NHANES III) and 6,962 participants from the combined NHANES 1999–2006 were
done. The revised National Cholesterol Education Program Adult Treatment Panel III deﬁnition
was used to calculate MetSyn.
RESULTS — Both the unadjusted prevalence (27.9  1.1% to 34.1  0.8%, P  0.001) and
age-adjusted prevalence (29.2  1.0% to 34.2  0.7%, P  0.001) increased from NHANES III
to NHANES 1999–2006, respectively. Although MetSyn prevalence was highest in Mexican
Americans, signiﬁcant increases in prevalence occurred among non-Hispanic whites and non-
Hispanic blacks, especially among younger women.
CONCLUSIONS — The persistent increase of MetSyn among U.S. adults is a serious public
health concern because it raises the likelihood of increased prevalence of type 2 diabetes.
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T
he metabolic syndrome (MetSyn) is
a constellation of metabolic abnor-
malities and is associated with in-
creased risk of developing diabetes (1),
cardiovascular disease (2), and higher
mortality from all causes (3). Among the
few studies using nationally representa-
tive samples on MetSyn (4–9), Ford et al.
(9) estimated an increasing trend of
MetSyn prevalence by comparing the
Third National Health and Nutrition Ex-
amination Survey (NHANES III) and
NHANES1999–2000data.However,be-
cause of the smaller sample size of
NHANES 1999–2000, the change in
MetSyn prevalence for various subpopu-
lations, which is necessary to track age
and ethnicity speciﬁc trends, was not es-
timated. Therefore, the objective of this
study is to compare the prevalence of
MetSyn between NHANES III and
NHANES 1999–2006 among U.S. adults
of different races or ethnicities.
RESEARCH DESIGN AND
METHODS— We identiﬁed the cases
of MetSyn using the revised American
Heart Association/National Cholesterol
Education Program Adult Treatment
Panel III deﬁnition (10), including medi-
cation uses for appropriate MetSyn crite-
ria.Dataforthisstudywereobtainedfrom
public-use datasets of the NHANES III,
NHANES 1988–1994 (data release
11#1A), and four continuous NHANES
data releases: 1999–2000, 2001–2002,
2003–2004, and 2005–2006. Details of
survey and laboratory procedure of
NHANES are published elsewhere (11–
13). Data from NHANES 1999–2006
were combined for this study to produce
estimates of MetSyn for demographic
subpopulations (e.g., sex-age-race/
ethnicity) with greater statistical reliabil-
ity. Because the data on fasting
triglycerides and fasting glucose were re-
quired to identify MetSyn and those mea-
surements were done on a subsample
population, the sample weights for the
subsample were used in this study.
The appropriate sample weights for
combined NHANES 1999–2006 were
constructed using National Center for
Health Statistics guidelines (14). To
maintain the consistency of blood pres-
sure data between the two surveys, the
proceduredescribedbyFordetal.(9)was
followed.
The continuous NHANES measured
fasting glucose and serum triglycerides
from blood samples drawn in the morn-
ing; therefore, only participants who at-
tendedamorningexaminationsessionfor
NHANES III were included in this analy-
sis. Otherwise, the sample includes men
and nonpregnant women aged 20 years
who fasted for at least 8 h. The number of
participants in the ﬁnal analysis was
6,423 for NHANES III and 6,962 for
NHANES1999–2006.Statisticalanalyses
to calculate prevalence were performed
using the survey procedures in SAS soft-
ware version 9.1 (SAS Institute, Cary,
NC). The statistical signiﬁcance of the
changeinMetSynprevalencebetweenthe
two surveys was examined by Student t
test, in which the square root of the sum
of the squared standard errors was uti-
lized to calculate the pooled standard er-
ror of the difference in the mean.
RESULTS— The age-adjusted preva-
lence of four of the ﬁve metabolic abnor-
malities of MetSyn increased signiﬁcantly
between the surveys for women: abdom-
inalobesity46.01.4%to58.01.1%,
P  0.001; hypertriglyceridemia 24.7 
1.2% to 27.6  0.8%, P  0.042; high
blood pressure (HBP) 27.8  0.9% to
36.60.8%,P0.001;highfastingglu-
cose 24.2  1.2% to 29.2  1.0%, P 
0.002. However, for men, age-adjusted
prevalence signiﬁcantly increased in ab-
dominal obesity (30.4  1.6% to 41.1 
1.1%, P  0.001) and HBP (32.0  0.8%
to 40.0  0.7%, P  0.001) only. The
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216 DIABETES CARE, VOLUME 34, NUMBER 1, JANUARY 2011 care.diabetesjournals.orgTable 1—Age-speciﬁc (unadjusted) and age-adjusted (adjusted) prevalence of the metabolic syndrome among U.S. adults aged >20 years in
the NHANES III and NHANES 1999–2006
NHANES III NHANES 1999–2006
Absolute change % Relative change % P n % (SEM) n % (SEM)
Total
Unadjusted 6,423 27.9 (1.1) 6,962 34.1 (0.8) 6.3 22.6 0.001
Adjusted 6,423 29.2 (1.0) 6,962 34.2 (0.7) 5.0 17.0 0.001
Men
Unadjusted 3,059 29.3 (1.6) 3,582 34.2 (1.1) 4.9 16.8 0.012
Adjusted 3,059 31.4 (1.4) 3,582 34.9 (1.0) 3.5 11.2 0.046
Aged 20–39 years 1,217 15.7 (2.1) 1,229 20.2 (1.4) 4.4 28.1 0.080
Aged 40–59 years 839 36.3 (2.3) 1,114 41.2 (1.7) 5.0 13.7 0.083
Aged 60 years 1,003 50.3 (2.3) 1,239 49.9 (2.0) 0.4 0.8 0.899
Women
Unadjusted 3,364 26.5 (1.4) 3,380 34.1 (1.10) 7.5 28.4 0.001
Adjusted 3,364 27.1 (1.2) 3,380 33.3 (1.0) 6.2 22.8 0.001
Aged 20–39 years 1,447 10.7 (1.7) 1,061 16.7 (1.2) 6.0 55.5 0.003
Aged 40–59 years 943 30.2 (2.3) 1,113 36.3 (1.7) 6.2 20.4 0.033
Aged 60 years 974 50.2 (2.2) 1,206 56.8 (1.9) 6.6 13.1 0.022
NHW
Men
Unadjusted 1,284 30.8 (2.0) 1,881 37.0 (1.3) 6.3 20.3 0.010
Adjusted 1,284 32.1 (1.9) 1,881 36.5 (1.2) 4.4 13.8 0.048
Aged 20–39 years 337 16.6 (2.8) 523 22.3 (2.0) 5.8 35.0 0.090
Aged 40–59 years 361 37.1 (3.0) 618 42.2 (2.0) 5.1 13.7 0.164
Aged 60 years 586 50.4 (2.5) 740 51.4 (2.4) 1.0 2.1 0.762
Women
Unadjusted 1,462 26.5 (1.6) 1,725 33.3 (1.4) 6.8 25.6 0.001
Adjusted 1,462 26.2 (1.4) 1,725 31.4 (1.3) 5.2 20.0 0.007
Aged 20–39 years 446 9.1 (1.9) 483 16.0 (1.8) 6.8 74.5 0.010
Aged 40–59 years 411 29.4 (2.7) 543 33.0 (2.2) 3.7 12.6 0.292
Aged 60 years 605 50.2 (2.5) 699 55.2 (2.1) 5.0 9.9 0.121
NHB
Men
Unadjusted 762 20.2 (1.2) 634 22.0 (1.6) 1.8 8.8 0.372
Adjusted 762 23.1 (1.4) 634 24.9 (1.6) 1.9 8.0 0.388
Aged 20–39 years 375 13.9 (1.5) 261 11.9 (2.0) 2.0 14.1 0.439
Aged 40–59 years 210 24.3 (3.10) 192 26.6 (3.2) 2.3 9.3 0.613
Aged 60 years 177 36.9 (3.3) 181 44.6 (3.3) 7.7 21.0 0.098
Women
Unadjusted 913 26.4 (1.7) 656 34.3 (1.7) 7.9 30.0 0.001
Adjusted 913 30.6 (1.7) 656 36.5 (1.6) 5.9 19.3 0.014
Aged 20–39 years 472 12.6 (1.6) 244 18.9 (2.5) 6.3 49.8 0.036
Aged 40–59 years 268 35.6 (2.7) 230 40.7 (3.4) 5.1 14.2 0.241
Aged 60 years 173 53.3 (4.0) 182 59.9 (2.7) 6.6 12.3 0.180
Mexican American
Men
Unadjusted 893 28.5 (2.2) 810 29.4 (2.2) 0.9 3.3 0.767
Adjusted 893 37.8 (2.1) 810 36.6 (1.9) 1.2 3.1 0.671
Aged 20–39 years 457 17.6 (2.7) 324 18.9 (2.8) 1.3 7.3 0.743
Aged 40–59 years 226 48.0 (3.5) 228 44.4 (3.0) 3.6 7.5 0.433
Aged 60 years 210 56.1 (5.4) 258 54.5 (3.6) 1.6 2.8 0.810
Women
Unadjusted 853 33.1 (1.6) 741 36.4 (2.2) 3.3 10.0 0.222
Adjusted 853 41.7 (1.7) 741 42.6 (1.7) 0.9 2.2 0.701
Aged 20–39 years 475 19.8 (1.9) 241 20.9 (2.9) 1.1 5.3 0.758
Aged 40–59 years 217 51.4 (3.2) 244 49.6 (3.3) 1.8 3.5 0.699
Aged 60 years 161 63.6 (3.8) 256 68.6 (3.9) 5.1 8.0 0.352
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lesterol signiﬁcantly decreased in both
sexes(men:36.41.7%to27.61.0%,
P  0.001; women: 39.6  1.4% to
33.8  1.1%, P  0.001) between the
surveys.
Both age-adjusted and age-speciﬁc
prevalence of MetSyn for NHANES
1999–2006 were signiﬁcantly higher
than for NHANES III (Table 1). The un-
adjusted (P  0.012) and age-adjusted
(P  0.046) prevalence increased signiﬁ-
cantly between the two surveys for men;
however, there was no signiﬁcant change
in any of the three age-groups. For
women, both unadjusted and age-
adjusted (P  0.001) prevalence in-
creased signiﬁcantly between the two
surveys, with a signiﬁcant increase noted
in all three age-groups. Among non-
Hispanic White (NHW) subjects, both
men and women showed signiﬁcant in-
creases in unadjusted (men: P  0.010;
women: P  0.001) and age-adjusted
(men: P  0.048; women: P  0.007)
prevalence of MetSyn. However, when
classiﬁed by age-groups, only women
aged 20–39 years showed signiﬁcant in-
crease (P  0.010). Prevalence of MetSyn
did not change signiﬁcantly among non-
Hispanic Black (NHB) men (P  0.050)
between the two surveys, but NHB
women aged 20–39 years showed a sig-
niﬁcant increase in prevalence (P 
0.036). The age-adjusted prevalence of
MetSyn in NHANES 1999–2006 was
highest among Mexican Americans (men:
36.61.9%;women:42.61.7%)with
little change in this group from NHANES
III. Using the unadjusted prevalence rates
from combined sample population of
NHANES 1999–2006, we estimated that
about 32.4 million men and 35.3 million
women in U.S. had MetSyn. Among U.S.
adults with MetSyn, 50.6 million were
NHW,6.3millionwereNHB,and4.6
million were Mexican Americans.
The age-adjusted prevalence of U.S.
adults reporting diabetes (other than
pregnancy related) or having a fasting
blood glucose 126 mg/dl signiﬁcantly
increasedinbothsexes(men:8.10.6%
to 10.5  0.6%, P  0.005; women:
5.8  0.6% to 8.5  0.5%, P  0.001)
between the two surveys. The age-
adjusted prevalence of MetSyn among
U.S.menwithoutdiabetesdidnotchange
signiﬁcantly (27.6  1.4% to 30.6 
1.1%,P0.08);however,theprevalence
signiﬁcantly increased for women with-
out diabetes (24.0  1.2% to 29.4 
1.0%,P0.001),includingwomenaged
20–39 years (10.0  1.6% to 15.8 
1.2%, P  0.003) and aged 40–59 years
(25.8  2.4% to 31.6  1.7%, P 
0.049).
CONCLUSIONS— Ford et al. (9) es-
timated that 50 million U.S. adults in
1990 and 64 million in 2000 had
MetSyn, representing a 28% increase in
prevalence. From the combined
NHANES 1999–2006 data, we estimated
68 million U.S. adults had MetSyn, or a
further increase of 6%. The prevalence of
MetSyn in U.S. adults in 1999–2006 was
34.1  0.8% (after age adjustment
34.2  0.7%), which is a signiﬁcant in-
crease from 1988–1994, and more so in
women (28.4%) than in men (16.8%).
Further,inbothNHWandNHBtheprev-
alence of MetSyn signiﬁcantly increased
in women, particularly younger women
(aged 20–39 years). The increased prev-
alence of MetSyn was primarily due to in-
creases in abdominal obesity and HBP.
An increase in MetSyn prevalence is
expected to be followed by an increase in
diabetes prevalence, though of a lesser
magnitude. Between the two surveys,
there was a 4.3% increase in age-adjusted
prevalence of MetSyn among adults with-
out diabetes and a 2.6% increase in dia-
betes.Aswecontinuetoseeanincreasein
MetSyn, especially in certain ethnic
groupsandyoungerwomen,wewillseea
concomitant increase in diabetes and its
comorbidities and associated medical
costs.
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